Medicine
Desonide 0.5 mg/mL lotion
Desonide 0.5 mg/mL lotion is a generic prescription medicine for topical use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store between 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Desonide
- Brand
- Sold under the generic name
- Strength
- 0.5 mg/mL
- Dosage form
- Lotion
- Route
- Topical
- Packs
- 1 bottle and 6 more
- Manufacturers
- Alembic PharmaceuticalsIndiaSun Pharmaceutical IndustriesIndiaActavis PharmaBryant Ranch Prepack
- Origin register
- US FDA, United States
- Storage
- Store between 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D07AB08 Desonide
- HS code (indicative)
- 3004.32Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 28 May 2009
- Identifiers
- RxCUI 197572, 349351DailyMed set ID d210d307-72df-40fb-89c9-88663b0e4901, 84ceca9d-94af-46a2-be96-601892f2c535, ff5d4cd8-ab4d-4a9e-b84b-445c81eeea99 +2NDC 46708-550, 63629-8739, 0472-0803 +2Application ANDA213632, ANDA072354, ANDA202161
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle in 1 carton / 118 mL in 1 bottle | 46708-550-18 | Alembic PharmaceuticalsIndia | 26 March 2025 |
| 1 bottle in 1 carton / 59 mL in 1 bottle | 46708-550-59 | Alembic PharmaceuticalsIndia | 26 March 2025 |
| 1 bottle in 1 carton / 118 mL in 1 bottle | 62332-550-18 | Alembic PharmaceuticalsIndia | 28 August 2020 |
| 1 bottle in 1 carton / 59 mL in 1 bottle | 62332-550-59 | Alembic PharmaceuticalsIndia | 28 August 2020 |
| 1 bottle in 1 carton / 59 mL in 1 bottle | 51672-4079-4 | Sun Pharmaceutical IndustriesIndia | 31 October 2014 |
| 1 bottle in 1 carton / 118 mL in 1 bottle | 51672-4079-8 | Sun Pharmaceutical IndustriesIndia | 31 October 2014 |
| 1 bottle in 1 carton / 59 mL in 1 bottle | 0472-0803-02 | Actavis Pharma | 28 May 2009 |
| 1 bottle in 1 carton / 118 mL in 1 bottle | 0472-0803-04 | Actavis Pharma | 28 May 2009 |
| 1 bottle in 1 carton / 59 mL in 1 bottle | 63629-8739-1 | Bryant Ranch Prepack | 19 August 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 4 January 1972 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Desonide
Clinical summary
Desonide is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. It is available as cream, ointment and lotion for topical use. MedsAcross supplies Desonide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DesonideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Desonide prescribing information (Padagis Israel Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Desonide 0.5 mg/mL lotion for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.